Transport proteins are the molecular gatekeepers embedded in every cell membrane, controlling what gets in, what gets out, and how fast it happens. They fall into two broad camps: channels that form open passageways through the membrane and carriers that physically change shape to shuttle molecules from one side to the other. Some work passively, letting substances slide down their natural concentration gradients, while others burn cellular fuel to push molecules uphill. Without them, cells would have no way to absorb nutrients, fire nerve impulses, maintain their internal chemistry, or communicate with one another.
Channels and Carriers Are Built for Different Jobs
The simplest way to sort transport proteins is by how they move things. Channel proteins form a pore through the membrane, and when the pore is open, ions or water molecules rush through at enormous rates. Carrier proteins, by contrast, bind a molecule on one side, undergo a shape change, and release it on the other side. That shape change is slower than an open pore, but it gives carriers the ability to be highly selective and, in many cases, to move substances against their gradient.
The shape change shared by many carriers follows a pattern researchers call the alternating-access model. In this scheme the protein flips between two main states: one facing the inside of the cell and one facing the outside. The protein is never open to both sides simultaneously. Work on a zinc transporter called YiiP showed that a bundle of four helices rocks and twists to alternately expose the ion-binding site to each side of the membrane, using the rest of the protein as a stable scaffold.
Interestingly, the story is not fully captured by those two endpoint states alone. Simulations of a sodium-calcium exchanger revealed that the functional character of the transporter depends on intermediate conformations in which the pathway to the binding site is blocked from both sides at once. In other words, the “occluded” states between the two open states matter as much as the open states themselves for determining whether the protein works as an exchanger, a channel, or something in between.1PubMed Central. Conformational free-energy landscapes of a Na(+)/Ca(2+) exchanger explain its alternating-access mechanism and functional specificity
How Ion Channels Pick Their Passengers
Ion channels face a seemingly impossible task: they need to let one type of ion through at nearly the speed of free diffusion while blocking other ions that are almost the same size. Potassium channels are the classic example. Potassium ions line up single-file in the selectivity filter, interspersed with water molecules, and move through in a “knock-on” chain where each arriving ion bumps the one ahead of it forward. Sodium channels use a looser version of the same idea, with a wider filter that does not require the ion to shed all of its surrounding water molecules.2PubMed Central. Ion channels and ion selectivity
Sodium channels have an additional trick for keeping potassium out. The selectivity filter in bacterial sodium channels is lined with four glutamate residues whose chemical properties shift depending on which ion is present. When sodium is in the filter, the glutamates stay in a highly conductive state; when potassium is present, the glutamates become partially protonated and conductance drops. So selectivity is not purely a matter of pore size. It also involves the ion itself changing the chemistry of the filter it passes through.3PubMed Central. Ion channel selectivity through ion-modulated changes of selectivity filter pK(a) values
Channels also need a way to shut off. Voltage-gated calcium channels, for instance, use a feedback mechanism called calcium-dependent inactivation: once calcium flows through and accumulates near the channel, a sensor on the cytoplasmic side triggers the selectivity filter itself to close. Researchers identified a single conserved aspartate residue in the filter that is essential for this shutdown. Mutating it essentially eliminates inactivation without altering other channel properties, placing the “off switch” right at the narrowest point of the pore.4PubMed Central. A Selectivity Filter Gate Controls Voltage-Gated Calcium Channel Calcium-Dependent Inactivation
Aquaporins and the Problem of Moving Water Without Protons
Water crosses membranes slowly on its own, and cells that need to move large volumes quickly rely on aquaporins, a family of channel proteins found in nearly every tissue. The kidney alone has several types, and the brain relies heavily on aquaporin-4. The design challenge aquaporins solve is unusual: they need to conduct water molecules in a rapid single-file chain while absolutely blocking protons, which in solution hitch rides along hydrogen-bonded water chains.
For years the leading explanation was that aquaporins simply break the hydrogen-bond chain at a narrow point in the pore, interrupting the bucket-brigade that protons use to hop from one water molecule to the next. Simulations of aquaporin-1 showed that the main barrier to proton passage is actually an electrostatic field generated by a conserved structural motif at the center of the channel. The energy penalty this field imposes on a passing proton roughly matches the barrier that a bare lipid membrane already presents, so aquaporins do not create a new proton leak even while dramatically speeding up water flow.5PubMed. The mechanism of proton exclusion in the aquaporin-1 water channel Structural work on aquaporin-4 in the brain further supports the hydrogen-bond isolation model, showing eight water molecules arranged in the channel in a way that prevents them from forming a continuous proton wire.6PubMed. Mechanism of aquaporin-4’s fast and highly selective water conduction and proton exclusion
ATP-Powered Pumps That Move Ions Uphill
Passive channels and carriers can only move molecules downhill, from high concentration to low. Cells that need to build or maintain concentration gradients turn to primary active transporters, proteins that directly consume ATP. The most famous is the sodium-potassium pump (Na⁺/K⁺-ATPase), which sits in the outer membrane of virtually every animal cell, pushing three sodium ions out while pulling two potassium ions in per cycle. Because the ion counts are unequal, each cycle produces a small net charge difference across the membrane, contributing to the resting voltage that nerve and muscle cells depend on.7PubMed Central. Na+/K+-pump and neurotransmitter membrane receptors
The pump works by the same alternating-access principle described earlier, but driven by a chemical modification: a phosphate group from ATP is temporarily attached to the protein, forcing it to switch between inward-facing and outward-facing shapes. Detailed structural studies have identified more than 20 distinct conformational states in a single transport cycle, reflecting a remarkably intricate molecular machine.8PubMed Central. Multistate Kinetic Model of the Sodium-Potassium ATPase
A separate family of rotary ATPases uses a completely different mechanical strategy. Instead of rocking between two shapes, these proteins contain a central rotor that literally spins inside a ring of subunits, like a molecular turbine. In ATP synthase, the flow of protons down their gradient drives the rotor, and the resulting mechanical rotation forces the catalytic subunits to synthesize ATP. The same machinery can run in reverse, burning ATP to pump protons. Cryo-electron microscopy snapshots of 18 catalytic intermediates in a related rotary ATPase showed that the rotor does not spin immediately when ATP binds; instead, three events happen at once during each 120-degree rotation step: ATP hydrolysis at one subunit, ATP binding at a second, and product release at a third.9PubMed Central. Structural snapshots of V/A-ATPase reveal the rotary catalytic mechanism of rotary ATPases
ABC Transporters and Their Remarkably Broad Appetite
ATP-binding cassette (ABC) transporters form one of the largest protein families in biology, found in bacteria, plants, and animals alike. They use ATP hydrolysis to flip between inward-facing and outward-facing conformations, shuttling an astonishing variety of cargo: sugars, amino acids, metal ions, lipids, and drugs. Structural studies show that rigid-body rotations of the membrane-spanning portions of the protein, coupled to the opening and closing of the nucleotide-binding domains, translate the energy of ATP into physical movement of the substrate.10PubMed Central. Structural insights into ABC transporter mechanism
Most ABC transporters have two ATP-binding subunits that work together. In the histidine permease of Salmonella, for example, both subunits hydrolyze ATP, and one activates the other. When one of the two is experimentally disabled, the transporter still works but at half its normal rate.11PubMed. One intact ATP-binding subunit is sufficient to support ATP hydrolysis and translocation in an ABC transporter, the histidine permease P-glycoprotein, the most studied mammalian ABC exporter, uses a two-stroke ATP hydrolysis cycle in which the energy from each stroke reconfigures the transmembrane domain in a distinct way, powering substrates out of the cell.12PubMed Central. Energy transduction and alternating access of the mammalian ABC transporter P-glycoprotein
Piggybacking on Gradients With Secondary Active Transport
Not every uphill transport job requires burning ATP directly. Secondary active transporters tap into the ion gradients that primary pumps have already built. The basic principle is coupling: the spontaneous flow of a “driving” ion like sodium or a proton down its gradient provides the energy to drag another molecule in the desired direction.13PubMed Central. General principles of secondary active transporter function If both the driving ion and the cargo move the same direction, the transporter is called a symporter. If they move in opposite directions, it is an antiporter.
This strategy powers glucose absorption in the small intestine, where sodium-glucose cotransporters haul glucose into epithelial cells against its gradient, riding the sodium gradient maintained by the sodium-potassium pump on the opposite face of the cell. Once inside the cell, glucose exits through a separate family of facilitated glucose transporters (GLUTs) that work passively. The different GLUT family members vary widely in their affinity for glucose, with binding constants ranging from about 0.2 to 17 millimolar, which allows different tissues to fine-tune how aggressively they pull glucose from the blood.14PubMed Central. Functional properties and genomics of glucose transporters
Clearing Neurotransmitters From the Synapse
After a nerve impulse, the neurotransmitter released into the synaptic cleft needs to be removed quickly, or the signal never stops. Reuptake transporters on the presynaptic membrane handle this cleanup. The dopamine transporter (DAT) controls dopamine levels by pulling dopamine back out of the cleft, terminating dopaminergic signaling.15PubMed. Molecular basis for the dopamine reuptake and inhibition mechanism of human dopamine transporter The noradrenaline transporter (NET) does the same for noradrenaline on the presynaptic membrane.16PubMed. Molecular basis of human noradrenaline transporter reuptake and inhibition A similar transporter exists for serotonin.
These proteins are secondary active transporters that use the sodium gradient as their energy source. They are also among the most pharmacologically targeted transport proteins in medicine. Antidepressants such as SSRIs block the serotonin transporter, cocaine blocks the dopamine transporter, and drugs for ADHD target the noradrenaline transporter. Understanding the precise molecular basis of how these transporters bind both their natural cargo and their inhibitors is an active area of structural biology research, because small differences in binding geometry can mean the difference between a therapeutic drug and a substance of abuse.
Transport Within the Cell
Transport proteins are not confined to the outer membrane. Organelles have their own membranes with their own specialized transporters, and some of the most intricate molecular logistics in the cell happen at these internal borders.
Mitochondria, which produce most of a cell’s ATP, manufacture only a handful of their own proteins. The vast majority are made in the cytoplasm and must be imported through two membranes. The main entry gate on the outer membrane is the TOM complex (translocase of the outer membrane), which recognizes incoming proteins by a signal sequence at their front end.17PubMed Central. Structural overview of the translocase of the mitochondrial outer membrane complex After emerging from TOM’s channel, proteins headed for the inner compartment are handed off to the TIM23 complex on the inner membrane, through which they pass in an unfolded state.18eLife. Towards a molecular mechanism underlying mitochondrial protein import through the TOM and TIM23 complexes At specialized contact sites where the outer and inner membranes come close together, the TOM and TIM23 complexes can even form a temporary supercomplex, creating a direct import highway from the cytoplasm to the mitochondrial interior.19PubMed Central. Mitochondrial translocation contact sites: separation of dynamic and stabilizing elements in formation of a TOM-TIM-preprotein supercomplex
Lysosomes, the cell’s recycling centers, also depend on membrane transporters. As digestive enzymes inside the lysosome break down proteins and other macromolecules, the resulting amino acids and nutrients need to be exported back into the cytoplasm for reuse. Researchers have identified specific lysosomal transporters for this job, including one called Ypq1 that moves the amino acid lysine across the lysosomal membrane.20PubMed Central. Lysosomal membrane transporter purification and reconstitution for functional studies
The nucleus presents yet another transport challenge. Small molecules diffuse freely through the nuclear pore complex, but anything larger than roughly 40 kilodaltons needs help from shuttle proteins called karyopherins. These shuttles bind to disordered, flexible tails on the proteins that line the pore, and this specific binding lets them navigate through the pore’s mesh-like interior while other large molecules are excluded.21PubMed Central. Nucleocytoplasmic transport: a role for nonspecific competition in karyopherin-nucleoporin interactions
Flippases and the Two-Faced Membrane
Not all transport happens across the membrane. Some transport proteins move molecules within it. The two leaflets of a cell membrane do not have the same lipid composition: certain phospholipids are concentrated on the inner face while others dominate the outer face. This asymmetry is not a passive arrangement. It is actively maintained by a group of enzymes called flippases and floppases, which use ATP to drag specific lipids from one leaflet to the other.22PubMed. Physiological roles of transverse lipid asymmetry of animal membranes
One of the best-studied examples involves phosphatidylserine, a lipid that P4-ATPase flippases keep tucked away on the inner leaflet under normal conditions.23PubMed Central. Role of flippases, scramblases and transfer proteins in phosphatidylserine subcellular distribution When a cell dies or is damaged, scramblases (a third class of lipid-moving proteins that work without ATP) rapidly randomize the membrane, and phosphatidylserine appears on the outer surface. Immune cells recognize this exposed phosphatidylserine as an “eat me” signal and engulf the dead cell. This is one reason why membrane asymmetry is not a trivial bookkeeping exercise: it carries life-or-death signaling information. Recent work systematically knocking out flippases, floppases, and scramblases in mammalian cells has begun mapping the broader cellular consequences of losing lipid asymmetry, which appear to extend to changes in cellular energy metabolism.24bioRxiv. Disruption of Plasma Membrane Lipid Asymmetry Alters Cellular Energetics
When Transport Proteins Work Against Cancer Treatment
The broad substrate appetite of certain ABC transporters creates a serious problem in oncology. P-glycoprotein, also known as ABCB1, sits in the membranes of many cancer cells and acts as an efflux pump, recognizing a wide range of chemotherapy drugs and pushing them back out of the cell before they can do their job. This is a major contributor to multidrug resistance, one of the leading reasons chemotherapy stops working.25PubMed Central. Multidrug Resistance of Cancer Cells and the Vital Role of P-Glycoprotein The protein does not recognize a single drug; it pumps out a chemically diverse array of anticancer agents, which is what makes the resistance “multi-drug” rather than specific to one treatment.
Researchers have pursued small molecule inhibitors that block P-glycoprotein’s efflux activity, with the goal of restoring the tumor’s sensitivity to chemotherapy drugs. The approach has shown promise in the lab, though translating it into clinical success has proved difficult, partly because P-glycoprotein also plays protective roles in healthy tissues like the intestinal lining and the blood-brain barrier.26PubMed. Strategies to overcome cancer multidrug resistance (MDR) through targeting P-glycoprotein (ABCB1): An updated review Blocking the pump everywhere, not just in the tumor, can cause unintended toxicity. The challenge is specificity: finding a way to shut down P-glycoprotein in cancer cells while leaving it functional where the body needs it.
Transport Proteins in Plant Biology
Animal cells get most of the attention in textbook discussions of transport, but plants rely on membrane transporters just as heavily and for some unique purposes. Root cells need to absorb mineral nutrients like nitrate, phosphate, and potassium from the soil, often against steep concentration gradients and from highly variable soil solutions. These uptake processes are tightly integrated with hormonal signaling: plant hormones regulate which transporters are made, where they go, and how active they are, allowing the plant to adjust nutrient acquisition in response to drought, flooding, or nutrient-poor soil.27PubMed Central. Plant hormones and membrane transporters: integrating nutrient uptake, ion homeostasis, and stress responses through hormonal cross-talk
Guard cells in leaves, which control the opening and closing of stomata, are another showcase for transport proteins. Stomatal opening depends on the coordinated activity of potassium channels, anion channels, and proton pumps, all regulated by hormonal and environmental signals. When the plant needs to conserve water, the hormone abscisic acid triggers ion efflux from guard cells, causing them to lose turgor pressure and the stomatal pore to close. The entire process is fundamentally a transport-protein story.
Transport Proteins as Tools in Biotechnology
The principles of pore-forming transport proteins have been borrowed for technology far removed from their biological origins. Nanopore sequencing, now a commercially available method for reading DNA and RNA, threads a single nucleic acid strand through a protein pore while measuring tiny changes in electrical current as each base passes through. The approach offers rapid readout, portability, and the ability to sequence very long molecules in a single pass. Researchers are now adapting the same idea to try to sequence proteins at the single-molecule level, which would be a transformative tool for biomedical research and diagnostics.28PubMed. Nanopore DNA sequencing technologies and their applications towards single-molecule proteomics
Meanwhile, cryo-electron microscopy continues to reveal the structures of transport proteins that were previously too small, too flexible, or too membrane-embedded to study. A recent cryo-EM structure of human monocarboxylate transporter 10, which moves thyroid hormone precursors and aromatic amino acids, captured the protein in its inward-open state and, combined with computational modeling of the outward-open state, allowed researchers to propose how cargo specificity and transport are linked at the atomic level.29PubMed. Cryo-EM structure of the human monocarboxylate transporter 10 Structures like these are not just academic curiosities. They give drug designers three-dimensional blueprints for building molecules that can enhance, block, or redirect the activity of specific transporters, connecting basic biophysics directly to the medicine cabinet.